Effect of portacaval shunt on drug disposition in patients with cirrhosis
- 1 July 1986
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 91 (1) , 163-167
- https://doi.org/10.1016/0016-5085(86)90453-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mesocaval and distal splenorenal shunts: Effect on hepatic function, hepatic hemodynamics, and portal systemic encephalopathyJournal of Molecular Medicine, 1985
- Intraoperative Hemodynamic Investigations During Portacaval ShuntArchives of Surgery, 1984
- Determinants of Drug Disposition in Patients with Cirrhosis†Hepatology, 1983
- Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparationJournal of Pharmacokinetics and Biopharmaceutics, 1977
- A physiological approach to hepatic drug clearanceClinical Pharmacology & Therapeutics, 1975
- The Role of Hemodynamic Measurements in Portosystemic Shunt SurgeryPublished by American Medical Association (AMA) ,1974
- Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in ManCirculation, 1971
- Indocyanine Green Clearance and Estimated Hepatic Blood Flow during Mild to Maximal Exercise in Upright Man *Journal of Clinical Investigation, 1964
- HEPATIC WEDGE PRESSURE, BLOOD FLOW, VASCULAR RESISTANCE AND OXYGEN CONSUMPTION IN CIRRHOSIS BEFORE AND AFTER END-TO-SIDE PORTACAVAL SHUNT12Journal of Clinical Investigation, 1958